REGENXBIO Inc. ( RGNX) - Stock Earnings
RGNX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 6, 2026, midnight | — / — | — | — / — | — |
RGNX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -61.9 million USD | 29.7 million USD |
| 2025Q4 | -67.1 million USD | 30.3 million USD |
| 2026Q1 | -90.1 million USD | 6.4 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
RGNX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -263.5 million USD | 90.2 million USD |
| 2024 | -227.1 million USD | 83.3 million USD |
| 2025 | -193.9 million USD | 170.4 million USD |
| 2026 Est. | — | — |
RGNX
Price: $9.73
52 week price:
Earnings Per Share: -5.60 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 295200
Ebitda: -20.6 millionMarket Capitalization: 766.7 million